Therapeutic Potential of Mesenchymal Cell-Derived miRNA-150-5p-Expressing Exosomes in Rheumatoid Arthritis Mediated...

Area of Science:

• Immunology
• Cell Biology
• Biotechnology

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by synovial inflammation and joint destruction, often linked to angiogenesis.
• Exosomes, as intercellular communicators, transfer microRNAs (miRNAs) and are explored for therapeutic delivery.
• Mesenchymal stem cells (MSCs) are a source of therapeutic exosomes.

Purpose of the Study:

• To investigate the therapeutic efficacy of miR-150-5p-loaded exosomes derived from MSCs (Exo-150) in mitigating joint destruction in rheumatoid arthritis.
• To analyze the impact of Exo-150 on key molecular targets involved in RA pathogenesis, including matrix metalloproteinase-14 (MMP14) and vascular endothelial growth factor (VEGF).

Main Methods:

• Quantitative RT-PCR, ELISA, and Western blotting were used to assess miR-150-5p, MMP14, and VEGF expression in RA patient samples and cells.
• Immunohistochemistry was employed to evaluate angiogenesis.
• In vitro assays (HUVEC tube formation, transwell) and an in vivo collagen-induced arthritis mouse model were utilized to test Exo-150's effects.

Main Results:

• Exo-150 treatment decreased migration and invasion in RA fibroblast-like synoviocytes (FLS) and reduced angiogenesis in HUVECs by targeting MMP14 and VEGF.
• In a collagen-induced arthritis mouse model, Exo-150 injection led to reduced paw swelling and clinical scores.
• Exo-150 effectively inhibited synoviocyte hyperplasia and angiogenesis, thereby reducing joint destruction.

Conclusions:

• MSC-derived miR-150-5p exosomes (Exo-150) demonstrate significant therapeutic potential for rheumatoid arthritis.
• Exo-150 functions by inhibiting key pathways involved in RA, including MMP14 and VEGF, leading to reduced inflammation, angiogenesis, and joint destruction.
• Exosomes represent a promising cell-free therapeutic strategy for managing rheumatoid arthritis due to their ability to transfer miRNAs and modulate disease processes.